Income Statement HCA Healthcare, Inc.

Equities

HCA

US40412C1018

Healthcare Facilities & Services

Market Closed - Nyse Other stock markets 02:30:02 15/11/2025 am IST			5-day change	1st Jan Change
472.65 ^USD	-0.13%		-0.83%	+57.47%

13/11	Wells Fargo Adjusts Price Target on HCA Healthcare to $431 From $412, Maintains Equalweight Rating	MT
12/11	HCA Healthcare, Inc. Presents at UBS Global Healthcare Conference 2025, Nov-12-2025 09:30 AM

aa686a13052a8.TGsNKt1u1LnUuzgWgZRejYLX3RpXZhEbPao_AC3qox0.YSg4XZ9dgO-g8g5h1KIOoOymsE8bCX5te-FSdGa-5FAuWTVAkia9iKD6DA

Published financial data: HCA HEALTHCARE, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	5.15TCr	5.88TCr	6.02TCr	6.5TCr	7.06TCr
Total Revenues	5.15TCr	5.88TCr	6.02TCr	6.5TCr	7.06TCr
Cost of Goods Sold, Total	3.23TCr	3.63TCr	3.71TCr	3.94TCr	4.19TCr
Gross Profit	1.92TCr	2.25TCr	2.32TCr	2.56TCr	2.87TCr
Selling General & Admin Expenses, Total	92Cr	99Cr	98Cr	99Cr	104.9Cr
Depreciation & Amortization - (IS)	272.1Cr	285.3Cr	296.9Cr	307.7Cr	331.2Cr
Other Operating Expenses	838.4Cr	897.2Cr	1.02TCr	1.19TCr	1.38TCr
Other Operating Expenses, Total	1.2TCr	1.28TCr	1.41TCr	1.6TCr	1.81TCr
Operating Income	720.2Cr	967.8Cr	905.3Cr	962.7Cr	1.05TCr
Interest Expense, Total	-158.4Cr	-156.6Cr	-174.1Cr	-193.8Cr	-206.1Cr
Net Interest Expenses	-158.4Cr	-156.6Cr	-174.1Cr	-193.8Cr	-206.1Cr
Income (Loss) On Equity Invest.	5.4Cr	11Cr	4.5Cr	2.2Cr	2.3Cr
EBT, Excl. Unusual Items	567.2Cr	822.5Cr	735.7Cr	771.1Cr	850.9Cr
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Gain (Loss) On Sale Of Assets	-70L	162Cr	130.1Cr	-50L	1.4Cr
Legal Settlements	-	-	-	-	-
Other Unusual Items	-24Cr	-1.2Cr	-7.8Cr	-	-
EBT, Incl. Unusual Items	543Cr	983.3Cr	858Cr	770.6Cr	852.3Cr
Income Tax Expense	104.3Cr	211.2Cr	174.6Cr	161.5Cr	186.6Cr
Earnings From Continuing Operations	438.7Cr	772.1Cr	683.4Cr	609.1Cr	665.7Cr
Net Income to Company	438.7Cr	772.1Cr	683.4Cr	609.1Cr	665.7Cr
Minority Interest	-63Cr	-76Cr	-119.1Cr	-85Cr	-90Cr
Net Income - (IS)	375.4Cr	695.6Cr	564.3Cr	524.2Cr	576Cr
Net Income to Common Incl Extra Items	375.4Cr	695.6Cr	564.3Cr	524.2Cr	576Cr
Net Income to Common Excl. Extra Items	375.4Cr	695.6Cr	564.3Cr	524.2Cr	576Cr
Per Share Items
Net EPS - Basic	11.1	21.51	19.44	19.24	22.27
Basic EPS - Continuing Operations	11.1	21.51	19.44	19.24	22.27
Basic Weighted Average Shares Outstanding	34Cr	32Cr	29Cr	27Cr	26Cr
Net EPS - Diluted	10.93	21.16	19.15	18.97	22
Diluted EPS - Continuing Operations	10.93	21.16	19.15	18.97	22
Diluted Weighted Average Shares Outstanding	34Cr	33Cr	29Cr	28Cr	26Cr
Normalized Basic EPS	8.61	13.53	11.73	14.58	17.1
Normalized Diluted EPS	8.47	13.31	11.56	14.36	16.89
Dividend Per Share	0.43	1.92	2.24	2.4	2.64
Payout Ratio	4.08	8.97	11.57	12.61	11.98
American Depositary Receipts Ratio (ADR)	0.05	0.05	0.05	0.05	0.05
Supplemental Items
EBITDA	992.3Cr	1.25TCr	1.2TCr	1.27TCr	1.39TCr
EBITA	722.8Cr	970.3Cr	909.7Cr	964.7Cr	1.06TCr
EBIT	720.2Cr	967.8Cr	905.3Cr	962.7Cr	1.05TCr
EBITDAR	1.08TCr	1.35TCr	1.3TCr	1.37TCr	1.49TCr
Total Revenues (As Reported)	-	-	-	-	-
Effective Tax Rate - (Ratio)	19.21	21.48	20.35	20.96	21.89
Current Domestic Taxes	114.7Cr	208Cr	142.8Cr	133.1Cr	141.4Cr
Current Foreign Taxes	50L	1.5Cr	1.8Cr	30L	2Cr
Total Current Taxes	115.2Cr	209.5Cr	144.6Cr	133.4Cr	143.4Cr
Deferred Domestic Taxes	-11Cr	60L	29Cr	26Cr	42Cr
Deferred Foreign Taxes	30L	1.1Cr	1.2Cr	1.9Cr	70L
Total Deferred Taxes	-11Cr	1.7Cr	30Cr	28Cr	43Cr
Normalized Net Income	291.2Cr	437.56Cr	340.71Cr	397.04Cr	442.11Cr
Interest on Long-Term Debt	158.4Cr	156.6Cr	174.1Cr	193.8Cr	206.1Cr
Non-Cash Pension Expense	6.7Cr	6.4Cr	-1.6Cr	5.2Cr	3.2Cr
Supplemental Operating Expense Items
Net Rental Expense, Total	92Cr	99Cr	98Cr	99Cr	104.9Cr
Imputed Operating Lease Interest Expense	34Cr	35Cr	35Cr	38Cr	40Cr
Imputed Operating Lease Depreciation	58Cr	63Cr	62Cr	62Cr	65Cr
Stock-Based Comp., COGS (Total)	36Cr	44Cr	34Cr	26Cr	36Cr
Total Stock-Based Compensation	36Cr	44Cr	34Cr	26Cr	36Cr

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	179.3Cr	145.1Cr	91Cr	94Cr	193.3Cr
Short Term Investments	12Cr	10Cr	9.2Cr	8.7Cr	8.8Cr
Total Cash And Short Term Investments	190.9Cr	155.4Cr	100Cr	102.2Cr	202.1Cr
Accounts Receivable, Total	705.9Cr	810.6Cr	890.3Cr	996.6Cr	1.08TCr
Total Receivables	705.9Cr	810.6Cr	890.3Cr	996.6Cr	1.08TCr
Inventory	202.5Cr	198.6Cr	206.8Cr	202.1Cr	173.8Cr
Other Current Assets, Total	134Cr	189.6Cr	167.2Cr	191.8Cr	185.9Cr
Total Current Assets	1.23TCr	1.35TCr	1.36TCr	1.49TCr	1.64TCr
Gross Property Plant And Equipment	5.13TCr	5.35TCr	5.68TCr	6.08TCr	6.46TCr
Accumulated Depreciation	-2.61TCr	-2.73TCr	-2.92TCr	-3.08TCr	-3.31TCr
Net Property Plant And Equipment	2.52TCr	2.62TCr	2.76TCr	2.99TCr	3.15TCr
Long-term Investments	81Cr	89Cr	120.4Cr	123.3Cr	123.1Cr
Goodwill	820.9Cr	913.7Cr	929.4Cr	960.6Cr	977Cr
Other Intangibles, Total	37Cr	40Cr	36Cr	34Cr	32Cr
Accounts Receivable Long-Term	3.1Cr	4.4Cr	4.8Cr	3.4Cr	3.5Cr
Other Long-Term Assets, Total	52Cr	55Cr	25Cr	15Cr	20Cr
Total Assets	4.75TCr	5.07TCr	5.24TCr	5.62TCr	5.95TCr
Liabilities
Accounts Payable, Total	353.5Cr	411.1Cr	423.9Cr	423.3Cr	427.6Cr
Accrued Expenses, Total	402.1Cr	424.7Cr	433.3Cr	510.3Cr	527.3Cr
Current Portion of Long-Term Debt	8.1Cr	10Cr	24Cr	225.8Cr	453.6Cr
Current Portion of Leases	51Cr	54Cr	50Cr	53Cr	50Cr
Other Current Liabilities	56Cr	59Cr	60Cr	53Cr	59Cr
Total Current Liabilities	870.4Cr	958.2Cr	990.2Cr	1.27TCr	1.52TCr
Long-Term Debt	3.03TCr	3.38TCr	3.71TCr	3.66TCr	3.77TCr
Long-Term Leases	216.7Cr	233.2Cr	233.1Cr	244.4Cr	248.7Cr
Other Non Current Liabilities	338Cr	357.4Cr	314.3Cr	342.4Cr	358.5Cr
Total Liabilities	4.46TCr	4.93TCr	5.25TCr	5.52TCr	5.9TCr
Common Stock, Total	30L	30L	30L	30L	30L
Additional Paid In Capital	29Cr	-	-	-	-
Retained Earnings	78Cr	-53Cr	-228Cr	-135.2Cr	-211.5Cr
Comprehensive Income and Other	-50Cr	-40Cr	-49Cr	-42Cr	-39Cr
Total Common Equity	57Cr	-93Cr	-276.7Cr	-177.4Cr	-249.9Cr
Minority Interest	232Cr	242.2Cr	269.4Cr	283.4Cr	305.4Cr
Total Equity	289.2Cr	148.9Cr	-7.3Cr	106Cr	56Cr
Total Liabilities And Equity	4.75TCr	5.07TCr	5.24TCr	5.62TCr	5.95TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	34Cr	30Cr	28Cr	26Cr	25Cr
ECS Total Common Shares Outstanding	34Cr	31Cr	28Cr	27Cr	25Cr
Book Value / Share	1.69	-3.05	-9.98	-6.68	-10
Tangible Book Value	-800.6Cr	-1.05TCr	-1.24TCr	-1.17TCr	-1.26TCr
Tangible Book Value Per Share	-23.59	-34.28	-44.78	-44.13	-50.37
Total Debt	3.31TCr	3.67TCr	4.02TCr	4.19TCr	4.52TCr
Net Debt	3.12TCr	3.52TCr	3.92TCr	4.08TCr	4.32TCr
Debt Equivalent of Unfunded Proj. Benefit Obligation	45Cr	46Cr	35Cr	33Cr	34Cr
Debt Equivalent Oper. Leases	738.4Cr	791.2Cr	780.8Cr	795.2Cr	839.2Cr
Minority Interest, Total (Incl. Fin. Div)	232Cr	242.2Cr	269.4Cr	283.4Cr	305.4Cr
Equity Method Investments, Total	42Cr	45Cr	82Cr	76Cr	66Cr
Account Code - Inventory Valuation	5	5	5	5	5
Land - (BS)	226.9Cr	249.6Cr	279.9Cr	312Cr	329.5Cr
Buildings, Total	1.85TCr	1.92TCr	2.02TCr	2.16TCr	2.27TCr
Machinery, Total	2.71TCr	2.83TCr	3TCr	3.2TCr	3.47TCr
Full Time Employees	2L	2L	2L	2L	2L
Part Time Employees	80T	80T	87T	90T	90T
Accumulated Allowance for Doubtful Accounts (Supple)	610.8Cr	678.4Cr	678Cr	728.3Cr	777.3Cr

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	375.4Cr	695.6Cr	564.3Cr	524.2Cr	576Cr
Depreciation & Amortization - CF	269.5Cr	282.8Cr	292.5Cr	305.7Cr	329.6Cr
Amortization of Goodwill and Intangible Assets - (CF)	2.6Cr	2.5Cr	4.4Cr	2Cr	1.6Cr
Depreciation & Amortization, Total	272.1Cr	285.3Cr	296.9Cr	307.7Cr	331.2Cr
Amortization of Deferred Charges, Total - (CF)	3Cr	2.7Cr	2.9Cr	3.5Cr	3.5Cr
(Gain) Loss From Sale Of Asset	70L	-162Cr	-130.1Cr	50L	-1.4Cr
Stock-Based Compensation (CF)	36Cr	44Cr	34Cr	26Cr	36Cr
Other Operating Activities, Total	108Cr	81Cr	199.3Cr	126.7Cr	116.7Cr
Change In Accounts Receivable	33Cr	-96Cr	-80Cr	-94Cr	-80Cr
Change In Inventories	-30Cr	-54Cr	-5.9Cr	-13Cr	33Cr
Change In Accounts Payable	125.5Cr	100Cr	-30Cr	60Cr	36Cr
Change in Other Net Operating Assets	-	-	-	-	-
Cash from Operations	923.2Cr	895.9Cr	852.2Cr	943.1Cr	1.05TCr
Capital Expenditure	-283.5Cr	-357.7Cr	-439.5Cr	-474.4Cr	-487.5Cr
Cash Acquisitions	-57Cr	-110.5Cr	-22Cr	-64Cr	-27Cr
Divestitures	6.8Cr	216Cr	123.7Cr	19Cr	33Cr
Investment in Marketable and Equity Securities, Total	-2Cr	-12Cr	1.4Cr	-11Cr	-12Cr
Other Investing Activities, Total	-3.8Cr	-40L	-2.1Cr	-1.9Cr	-50L
Cash from Investing	-339.3Cr	-264.3Cr	-338.9Cr	-531.7Cr	-493.3Cr
Long-Term Debt Issued, Total	270Cr	712.4Cr	611.7Cr	322.4Cr	749.5Cr
Total Debt Issued	270Cr	712.4Cr	611.7Cr	322.4Cr	749.5Cr
Long-Term Debt Repaid, Total	-591.7Cr	-386.9Cr	-283Cr	-192.9Cr	-429Cr
Total Debt Repaid	-591.7Cr	-386.9Cr	-283Cr	-192.9Cr	-429Cr
Repurchase of Common Stock	-44Cr	-821.5Cr	-700Cr	-381.1Cr	-604.2Cr
Common Dividends Paid	-15Cr	-62Cr	-65Cr	-66Cr	-69Cr
Common & Preferred Stock Dividends Paid	-15Cr	-62Cr	-65Cr	-66Cr	-69Cr
Other Financing Activities, Total	-87Cr	-107.1Cr	-129Cr	-92Cr	-105.5Cr
Cash from Financing	-467.7Cr	-665.5Cr	-565.6Cr	-409.4Cr	-458.2Cr
Foreign Exchange Rate Adjustments	1Cr	-30L	-2Cr	70L	-10L
Net Change in Cash	117.2Cr	-34Cr	-54Cr	2.7Cr	100Cr
Supplemental Items
Cash Interest Paid	160.7Cr	150.2Cr	166.2Cr	189.2Cr	193.8Cr
Cash Income Tax Paid (Refund)	100.2Cr	218.2Cr	117.5Cr	138.6Cr	184.4Cr
Levered Free Cash Flow	464.72Cr	407.8Cr	308.2Cr	287.36Cr	391.58Cr
Unlevered Free Cash Flow	560.72Cr	502.98Cr	414.11Cr	404.99Cr	516.89Cr
Change In Net Working Capital	-86Cr	74Cr	43Cr	56Cr	22Cr
Net Debt Issued / Repaid	-321.7Cr	325.5Cr	328.7Cr	129.5Cr	320.5Cr

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	9.73	12.32	10.97	11.08	11.39
Return on Total Capital	12.68	16.3	14.44	14.49	14.86
Return On Equity %	377.05	352.48	965.25	1.23T	824.4
Return on Common Equity	-335.78	-3.85T	-305.03	-230.87	-269.6
Margin Analysis
Gross Profit Margin %	37.32	38.28	38.48	39.37	40.62
SG&A Margin	1.79	1.68	1.62	1.53	1.49
EBITDA Margin %	19.26	21.33	19.96	19.55	19.63
EBITA Margin %	14.03	16.52	15.1	14.85	14.96
EBIT Margin %	13.98	16.47	15.03	14.82	14.94
Income From Continuing Operations Margin %	8.51	13.14	11.35	9.38	9.43
Net Income Margin %	7.28	11.84	9.37	8.07	8.16
Net Avail. For Common Margin %	7.28	11.84	9.37	8.07	8.16
Normalized Net Income Margin	5.65	7.45	5.66	6.11	6.26
Levered Free Cash Flow Margin	9.02	6.94	5.12	4.42	5.55
Unlevered Free Cash Flow Margin	10.88	8.56	6.88	6.23	7.32
Asset Turnover
Asset Turnover	1.11	1.2	1.17	1.2	1.22
Fixed Assets Turnover	2.07	2.29	2.24	2.26	2.3
Receivables Turnover (Average Receivables)	7.13	7.75	7.08	6.89	6.8
Inventory Turnover (Average Inventory)	16.68	18.08	18.28	19.27	22.31
Short Term Liquidity
Current Ratio	1.42	1.41	1.38	1.18	1.08
Quick Ratio	1.03	1.01	1	0.87	0.84
Operating Cash Flow to Current Liabilities	1.06	0.93	0.86	0.75	0.69
Days Sales Outstanding (Average Receivables)	51.31	47.11	51.54	53	53.81
Days Outstanding Inventory (Average Inventory)	21.95	20.19	19.97	18.95	16.41
Average Days Payable Outstanding	36.29	38.52	41.03	39.3	37.39
Cash Conversion Cycle (Average Days)	36.97	28.77	30.47	32.65	32.83
Long Term Solvency
Total Debt/Equity	1.14T	2.47T	-55.07T	3.95T	8.15T
Total Debt / Total Capital	91.97	96.1	100.18	97.53	98.79
LT Debt/Equity	1.12T	2.42T	-54.06T	3.69T	7.24T
Long-Term Debt / Total Capital	90.33	94.44	98.35	91.04	87.78
Total Liabilities / Total Assets	93.91	97.07	100.14	98.11	99.07
EBIT / Interest Expense	4.55	6.18	5.2	4.97	5.12
EBITDA / Interest Expense	6.85	8.63	7.47	7.07	7.23
(EBITDA - Capex) / Interest Expense	5.06	6.35	4.94	4.62	4.87
Total Debt / EBITDA	3.05	2.72	3.09	3.06	3.03
Net Debt / EBITDA	2.88	2.6	3.02	2.98	2.9
Total Debt / (EBITDA - Capex)	4.13	3.69	4.67	4.67	4.51
Net Debt / (EBITDA - Capex)	3.89	3.54	4.56	4.56	4.31
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	0.38	14.01	2.52	7.86	8.67
Gross Profit, 1 Yr. Growth %	-0.34	16.6	3.05	10.36	12.12
EBITDA, 1 Yr. Growth %	1.11	25.52	-4.06	5.67	9.1
EBITA, 1 Yr. Growth %	-0.03	33.14	-6.25	6.05	9.51
EBIT, 1 Yr. Growth %	-0.22	33.27	-6.46	6.34	9.57
Earnings From Cont. Operations, 1 Yr. Growth %	5.84	76	-11.49	-10.87	9.29
Net Income, 1 Yr. Growth %	7.1	85.3	-18.88	-7.11	9.88
Normalized Net Income, 1 Yr. Growth %	5.58	48.35	-22.13	16.53	11.37
Diluted EPS Before Extra, 1 Yr. Growth %	8.54	93.6	-9.5	-0.94	15.97
Accounts Receivable, 1 Yr. Growth %	-4.47	14.83	9.83	11.94	8.33
Inventory, 1 Yr. Growth %	9.52	-1.93	4.13	-2.27	-14
Net Property, Plant and Equip., 1 Yr. Growth %	2.75	3.78	5.59	8.26	5.42
Total Assets, 1 Yr. Growth %	5.4	6.85	3.34	7.2	5.87
Tangible Book Value, 1 Yr. Growth %	-27.72	30.81	18.59	-5.64	7.45
Common Equity, 1 Yr. Growth %	-120.37	-263.11	196.57	-35.89	40.87
Cash From Operations, 1 Yr. Growth %	21.44	-2.96	-4.88	10.67	11.48
Capital Expenditures, 1 Yr. Growth %	-31.82	26.17	22.87	7.94	2.76
Levered Free Cash Flow, 1 Yr. Growth %	144.17	-12.95	-24.42	-6.76	36.29
Unlevered Free Cash Flow, 1 Yr. Growth %	86.09	-10.9	-17.67	-2.2	27.65
Dividend Per Share, 1 Yr. Growth %	-73.12	346.51	16.67	7.14	10
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	5.07	6.98	8.11	5.16	8.27
Gross Profit, 2 Yr. CAGR %	4.74	7.97	9.61	6.64	11.24
EBITDA, 2 Yr. CAGR %	5.47	13	9.74	0.69	7.36
EBITA, 2 Yr. CAGR %	4.32	15.94	11.92	-0.16	8.01
EBIT, 2 Yr. CAGR %	4.13	15.79	11.65	-0.26	7.93
Earnings From Cont. Operations, 2 Yr. CAGR %	-0.02	36.48	24.81	-11.18	-1.3
Net Income, 2 Yr. CAGR %	-0.44	40.88	22.6	-13.19	1.03
Normalized Net Income, 2 Yr. CAGR %	8.57	25.95	7.48	-4.74	13.9
Diluted EPS Before Extra, 2 Yr. CAGR %	1.26	44.96	32.37	-5.32	7.18
Accounts Receivable, 2 Yr. CAGR %	1.89	4.74	12.3	10.88	10.12
Inventory, 2 Yr. CAGR %	8.13	3.64	1.06	0.88	-8.33
Net Property, Plant and Equip., 2 Yr. CAGR %	12.99	3.26	4.68	6.92	6.83
Total Assets, 2 Yr. CAGR %	10.06	6.12	5.08	5.25	6.53
Tangible Book Value, 2 Yr. CAGR %	-21.23	-2.76	24.55	5.78	0.69
Common Equity, 2 Yr. CAGR %	-66.01	-42.36	119.94	37.89	-4.97
Cash From Operations, 2 Yr. CAGR %	16.85	8.56	-3.92	2.6	11.07
Capital Expenditures, 2 Yr. CAGR %	-10.92	-7.25	24.51	15.16	5.32
Levered Free Cash Flow, 2 Yr. CAGR %	38.91	46.38	-18.89	-16.06	12.71
Unlevered Free Cash Flow, 2 Yr. CAGR %	27.04	29.2	-14.35	-10.27	11.71
Dividend Per Share, 2 Yr. CAGR %	-44.58	9.54	128.24	11.8	8.56
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	5.72	7.97	5.47	8.03	6.32
Gross Profit, 3 Yr. CAGR %	5.8	8.67	6.3	9.86	8.44
EBITDA, 3 Yr. CAGR %	6.62	12	7	8.37	3.41
EBITA, 3 Yr. CAGR %	6.08	13.47	8.02	9.93	2.96
EBIT, 3 Yr. CAGR %	5.95	13.37	7.84	9.85	2.91
Earnings From Cont. Operations, 3 Yr. CAGR %	16.94	20.72	18.14	11.56	-4.82
Net Income, 3 Yr. CAGR %	19.21	22.47	17.2	11.77	-6.1
Normalized Net Income, 3 Yr. CAGR %	9.31	20.99	7.3	10.41	0.35
Diluted EPS Before Extra, 3 Yr. CAGR %	22.47	25.68	23.89	20.18	1.31
Accounts Receivable, 3 Yr. CAGR %	2.76	6.04	6.41	12.18	10.02
Inventory, 3 Yr. CAGR %	8.78	4.67	3.8	-0.07	-4.35
Net Property, Plant and Equip., 3 Yr. CAGR %	12.12	9.83	4.03	5.86	6.42
Total Assets, 3 Yr. CAGR %	9.08	8.98	5.19	5.78	5.46
Tangible Book Value, 3 Yr. CAGR %	-17.39	-6.72	3.89	13.54	6.33
Common Equity, 3 Yr. CAGR %	-56.2	-42.66	-0.49	45.83	38.88
Cash From Operations, 3 Yr. CAGR %	19.38	9.84	3.88	0.71	5.48
Capital Expenditures, 3 Yr. CAGR %	-2.03	0.04	1.86	18.72	10.87
Levered Free Cash Flow, 3 Yr. CAGR %	40.23	19.19	17.43	-15.03	-1.34
Unlevered Free Cash Flow, 3 Yr. CAGR %	27.42	13.13	11.18	-10.48	0.91
Dividend Per Share, 3 Yr. CAGR %	-	11.1	11.87	77.38	11.2
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	5.37	7.21	6.67	6.84	6.58
Gross Profit, 5 Yr. CAGR %	5.2	7.51	7.37	7.85	8.25
EBITDA, 5 Yr. CAGR %	4.75	8.95	7.99	7.33	7.15
EBITA, 5 Yr. CAGR %	3.92	9.38	8.48	7.75	7.91
EBIT, 5 Yr. CAGR %	3.84	9.32	8.38	7.71	7.88
Earnings From Cont. Operations, 5 Yr. CAGR %	10.23	17.6	20.03	6.77	9.94
Net Income, 5 Yr. CAGR %	12.01	19.2	20.56	6.72	10.45
Normalized Net Income, 5 Yr. CAGR %	6.26	13.74	8.85	9.95	9.9
Diluted EPS Before Extra, 5 Yr. CAGR %	16.98	23.72	26.34	12.22	16.92
Accounts Receivable, 5 Yr. CAGR %	3.66	6.8	6.47	7.95	7.88
Inventory, 5 Yr. CAGR %	7.07	5.73	5.62	3.13	-1.23
Net Property, Plant and Equip., 5 Yr. CAGR %	10.93	9.87	9.08	8.66	5.14
Total Assets, 5 Yr. CAGR %	7.72	8.49	7.46	7.47	5.72
Tangible Book Value, 5 Yr. CAGR %	-10.99	-5.65	-2.64	-1.91	2.6
Common Equity, 5 Yr. CAGR %	-40.39	-33.73	-16.47	-18.55	-2.3
Cash From Operations, 5 Yr. CAGR %	14.29	9.65	9.45	6.88	6.7
Capital Expenditures, 5 Yr. CAGR %	3.6	5.32	7.83	5.83	3.23
Levered Free Cash Flow, 5 Yr. CAGR %	13.29	8.74	12.83	3.6	15.52
Unlevered Free Cash Flow, 5 Yr. CAGR %	9.91	6.24	8.85	3.11	11.4
Dividend Per Share, 5 Yr. CAGR %	-	-	-	11.38	10.53